Tammam AS, Gahlan AA, Taher MA, Haredy AM. Hantzsch Condensation Reaction as a Spectrofluorometric Method for Determination of Alogliptin, an Anti-diabetic Drug, in Pure, Tablet, Human, and rat plasma.
LUMINESCENCE 2021;
37:543-550. [PMID:
34907663 DOI:
10.1002/bio.4178]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2021] [Revised: 11/13/2021] [Accepted: 11/29/2021] [Indexed: 11/07/2022]
Abstract
To analyze alogliptin in its pharmaceutical dosage forms and human plasma, a sensitive, inexpensive, simple, and precise spectrofluorimetric method was developed and tested. Also, this method was used to investigate the drug pharmacokinetic behavior in the blood of rats. It is based on the Hantzsch reaction, which produces yellowish luminous products that can be detected spectrofluorometrically at 480 and 415 nm, emission, and excitation, respectively, when the primary amine group in the examined drug reacts with acetylacetone and formaldehyde. Several experimental parameters that affect the reaction product's development and stability were explored and improved. The curve of fluorescence and concentration for alogliptin was linear in the concentration range of 0.05-3.60 μg ml-1 . According to ICH criteria, the proposed approach was validated. The method was successfully utilized to evaluate the examined drug in dose formulations and spiked human plasma with high accuracy.
Collapse